Jove
Visualize
Contact Us

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

574
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
574
Cognitive Dissonance01:38

Cognitive Dissonance

36.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
36.8K
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

918
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
918
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

George Papanicolaou (1883-1962): Discoverer of the Pap Smear.

Journal of obstetrics and gynaecology of India·2018
Same author

The isolation of morphine by Serturner.

Indian journal of anaesthesia·2016
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 22, 2026

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
08:17

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

Published on: February 27, 2018

17.0K

H3 antagonists and postoperative cognitive dysfunction.

Chandrasekhar Krishnamurti1

  • 1Department of Anesthesiology, NRI Institute of Medical Sciences, Visakhapatnam, Andhra Pradesh, India.

Journal of Anaesthesiology, Clinical Pharmacology
|July 16, 2019
PubMed
Summary
This summary is machine-generated.

Histamine (HA) research has uncovered its crucial roles in health and disease, leading to valuable therapeutics. Targeting histamine receptors, particularly H3 receptors, shows promise for treating neurological disorders.

Keywords:
Cognitionhistamine H3 receptorpostoperative cognitive dysfunction

More Related Videos

Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
03:26

Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research

Published on: December 8, 2023

1.9K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.0K

Related Experiment Videos

Last Updated: Jan 22, 2026

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
08:17

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

Published on: February 27, 2018

17.0K
Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
03:26

Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research

Published on: December 8, 2023

1.9K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.0K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Biochemistry

Background:

  • Histamine (HA), synthesized in 1907, mediates biological actions via four receptor subtypes (H1, H2, H3, H4).
  • H1 and H2 receptors are established drug targets for allergies and peptic ulcers, respectively.
  • The H3 receptor (H3R), a G-protein-coupled receptor discovered in 1983, presents novel therapeutic potential.

Purpose of the Study:

  • To review the historical context and evolving understanding of histamine's role in biological systems.
  • To highlight the significance of histamine receptor subtypes, particularly H3R, in physiological and pathological processes.
  • To explore the therapeutic implications of targeting H3R for neurological conditions.

Main Methods:

  • Literature review of histamine synthesis, isolation, and receptor characterization.
  • Analysis of the molecular mechanisms and pharmacological properties of histamine receptor subtypes.
  • Examination of drug development targeting H3 receptor antagonists.

Main Results:

  • Histamine's diverse roles in health and disease have been elucidated through extensive research.
  • Targeting specific histamine receptors has yielded significant therapeutic advancements.
  • Development of potent and selective H3 receptor antagonists shows promise for treating neurological disorders.

Conclusions:

  • Histamine research has led to the development of drugs with substantial therapeutic value.
  • The H3 receptor represents a key target for novel therapeutic strategies.
  • H3 receptor antagonists hold potential for treating a wide range of neurological diseases, including postoperative cognitive dysfunction.